-
What value should clinicians place on real-world evidence?
The question about real-world evidence is no longer whether data collected during routine clinical processes can be useful, but rather, how can it best be used? Mikhail Kosiborod, MD, and Hertzel C. Gerstein MD, MSc, FRCPC, will address that question during Saturday’s Current Issues session “What are the Contributions of the Evolving Real-World Evidence?”
-
Professional Interest Group Award recipients
The ADA’s 15 members-only Interest Groups provide a forum for the exchange of information in specific areas of diabetes research and care. Five recipients of Professional Interest Groups Awards will deliver honorary lectures and remarks at the Scientific Sessions.
-
Welcome to the 79th Scientific Sessions
The American Diabetes Association’s 79th Scientific Sessions begins today at the Moscone Center in San Francisco, CA. ADAMeetingNews.org spoke to Jose C. Florez, MD, PhD, Chair of the 79th Scientific Sessions Meeting Planning Committee, who highlighted several sessions in this year’s program that he’s particularly excited about.
-
Results from 10 major studies to be presented at the Scientific Sessions
New data from cardiovascular prevention trials are just some of the highly anticipated study announcements that will be presented at the 79th Scientific Sessions. Check out the schedule of sessions featuring major study results.
-
Experts will explore current trends, issues in CGM
Friday’s symposium “Pains and Gains in Continuous Glucose Monitoring (CGM)” will explore a range of topics, including advances in device technology, outcomes and indications, CGM in special populations, and uniform metrics in CGM. Roy W. Beck, MD, PhD, and Anders L. Carlson, MD, preview the session.
-
Q&A: Treating kidney and cardiovascular disease in patients with diabetes
Emerging trial data are changing approaches to kidney disease, diabetes, and cardiovascular disease. ADAMeetingNews.org spoke with George Bakris, MD, and Amanda Vest, MBBS, MPH, who will review the latest data during Friday’s symposium “Diabetic Kidney Disease and Cardiovascular Disease in Diabetes.”
-
Pathway to Stop Diabetes: The American Diabetes Association’s Premier Research Program
Pathway to Stop Diabetes® program is a bold, forward-thinking initiative dedicated to bringing 100 brilliant scientists to diabetes research. The 79th Scientific Sessions program features 25 presentations by 19 Pathway scientists. Please join us today at 6:30 p.m. for the Pathway poster reception to meet Pathway scientists and see outcomes from the program.
-
Looking ahead to Saturday at the Scientific Sessions
Click to view a last-minute additon to the Scientific Sessions program, Saturday’s meeting hours, the schedule of highly anticipated study announcements, and the live match schedule in the Women’s World Cup Viewing Lounge.